Polyphenols against infectious diseases: Controlled release nano-formulations

被引:31
作者
Murthy, Namratha Turuvekere Vittala [1 ]
Agrahari, Vibhuti [2 ]
Chauhan, Harsh [1 ]
机构
[1] Creighton Univ, Sch Pharm & Hlth Profess, Omaha, NE 68178 USA
[2] Oklahoma Univ, Coll Pharm, Dept Pharmaceut Sci, Oklahoma City, OK 73117 USA
关键词
Natural products; Nanoparticles; Drug delivery systems; Bacterial resistance; Nanomedicine; SOLID LIPID NANOPARTICLES; DRUG-DELIVERY SYSTEMS; STAPHYLOCOCCUS-AUREUS; IN-VITRO; BACTERIAL-RESISTANCE; CYTOPLASMIC MEMBRANE; EPICATECHIN GALLATE; AMPHOTERICIN-B; LIPOSOMES; ANTIBIOTICS;
D O I
10.1016/j.ejpb.2021.02.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The emergence of multi-drug resistant (MDR) pathogens has become a global threat and a cause of significant morbidity and mortality around the world. Natural products have been used as a promising approach to counter the infectious diseases associated with these pathogens. The application of natural products and their derivatives especially polyphenolic compounds as antibacterial agents is an active area of research, and prior studies have successfully treated a variety of bacterial infections using these polyphenolic compounds. However, delivery of polyphenolic compounds has been challenging due to their physicochemical properties and often poor aqueous solubility. In this regard, nanotechnology-based novel drug delivery systems offer many advantages, including improving bioavailability and the controlled release of polyphenolic compounds. This review summarizes the pharmacological mechanism and use of nano-formulations in developing controlled release delivery systems of naturally occurring polyphenols in infectious diseases.
引用
收藏
页码:66 / 79
页数:14
相关论文
共 131 条
[1]   Controlled Dual Release Study of Curcumin and a 4-Aminoquinoline Analog from Gum Acacia Containing Hydrogels [J].
Aderibigbe, Blessing ;
Sadiku, Emmanuel ;
Jayaramudu, Jarugala ;
Ray, Suprakas Sinha .
JOURNAL OF APPLIED POLYMER SCIENCE, 2015, 132 (10)
[2]   Facilitating the translation of nanomedicines to a clinical product: challenges and opportunities [J].
Agrahari, Vibhuti ;
Agrahari, Vivek .
DRUG DISCOVERY TODAY, 2018, 23 (05) :974-991
[3]   Advances and applications of block-copolymer-based nanoformulations [J].
Agrahari, Vibhuti ;
Agrahari, Vivek .
DRUG DISCOVERY TODAY, 2018, 23 (05) :1139-1151
[4]   Challenges associated and approaches for successful translation of nanomedicines into commercial products [J].
Agrahari, Vivek ;
Hiremath, Praveen .
NANOMEDICINE, 2017, 12 (08) :819-823
[5]   Influence of controlled release of resveratrol from electrospun fibers in combination with siRNA on leukemia cells [J].
Al-Attar, Thikrayat ;
Madihally, Sundararajan, V .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 123 :173-183
[6]  
alpha-Mangostin, C24H26O6 PUBCHEM
[7]   Quality by design compliant strategy for the development of a liquid chromatography-tandem mass spectrometry method for the determination of selected polyphenols in Diospyros kaki [J].
Ancillotti, C. ;
Orlandini, S. ;
Ciofi, L. ;
Pasquini, B. ;
Caprini, C. ;
Droandi, C. ;
Furlanetto, S. ;
Del Bubba, M. .
JOURNAL OF CHROMATOGRAPHY A, 2018, 1569 :79-90
[8]  
[Anonymous], Acinetobacter in Healthcare Settings
[9]  
[Anonymous], Rutin | C27H30O16 - PubChem
[10]  
[Anonymous], 2014, Antimicrobial Resistance: Tackling a crisis forthe health and wealth of nations, DOI DOI 10.1088/2053-1591/1/4/046305